Close Window

Digital Look Email A Friend

AstraZeneca's Covid drug meets trial endpoints

Published by Abigail Townsend on 16th May 2024

(Sharecast News) - AstraZeneca said on Thursday that its investigative drug sipavibart had shown positive results in preventing Covid-19 in vulnerable patients.

URL: http://www.digitallook.com/dl/news/story/34296606/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.